June 2, 2025

NeuroNews highlighted research led by the University of Cincinnati's Iris Davis and the University of Minnesota's Christopher Streib that revealed the potential advantages associated with electronic informed consent in acute ischemic stroke studies, including increased enrollment rates and improved adherence to consent documentation.

June 3, 2025

The University of Cincinnati is part of a collaborative national team spearheading research and wellness programming with the goal of improving care for adaptive athletes through the Para-Athlete Research for Wellness, Injury Prevention and Sports Medicine Excellence (PARA-WISE) registry.

June 3, 2025

MSN highlighted a study led by University of Cincinnati Cancer Center researchers that sheds new light on the mechanisms by which a major oncogene promotes and sustains lymphoma development and progression, paving the way for novel targeted therapies.

June 5, 2025

The Columbus Dispatch highlighted Grove City High School adaptive track athlete Eamon Castaldi who will join the University of Cincinnati's adaptive track and field team this fall.

June 12, 2025

The University of Cincinnati cut the ribbon on the Sheakley Indoor Practice Facility and Athletics Performance Center, culminating a two-year construction process for the $134-million, 210,000-square-foot complex that will redefine the student-athlete experience at UC.

June 17, 2025

University of Cincinnati and Case Western Reserve University researchers have received an Air Force Research Laboratory grant to test platelet-inspired nanotherapeutics to treat traumatic brain injuries and hemorrhages.

June 18, 2025

Cancer Network News highlighted research led by the University of Cincinnati Cancer Center's Zulfa Omer that found a novel drug was generally well tolerated and demonstrated early efficacy in patients with relapsed/refractory chronic lymphocytic leukemia.

June 23, 2025

The University of Cincinnati Cancer Center, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Jabez Biosciences are partnering to open a new phase 1 clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia, funded by a National Cancer Institute grant.

June 27, 2025

The University of Cincinnati's Robert Cohen, MD, spoke with Everyday Health to discuss new research that suggests diet soda drinkers with type 2 diabetes may have more success losing weight and achieving diabetes remission if they switch to water.

July 1, 2025

The University of Cincinnati's Robert Cohen, MD, commented to MedCentral on two new studies presented at the American Diabetes Association’s (ADA) 85th Scientific Sessions in Chicago.